SLU's Center for Vaccine Development receives $2.9 million to study new vaccine to combat TB

Saint Louis University's Center for Vaccine Development has received a $2.9 million award to study a new tuberculosis vaccine. With the award, researchers will continue studying the role of a special subset of T cells - gamma/delta T cells - in fighting TB. TB is a massive world health problem. About a third of the world's population is infected with TB, meaning they have TB bacterium in their bodies that might not cause active disease. TB is becoming increasingly resistant to current therapies and thus, we need a new approach to fight TB.
Source :      2015/7/11 11:13

خانه چاپ ارسال به دوستان نسخه متنی کوچک کردن متن بزرگ کردن متن دانلود خروجی پی دی اف خروجی میکروسافت ورد
0/10 (تعداد آرا 0 نفر )
Copyright © 2011 AASM. All Rights Reserved.